An interventional study of Radiation in Radiation Exposure, Radiation Exposure to Operator and Radiation Injuries, sponsored by Liverpool Heart and Chest Hospital NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by Liverpool Heart and Chest Hospital NHS Foundation Trust · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Radiation Injuries with a site in United Kingdom — 3 open to participants now, 4 under way, none of them phase 3. Radiation Injuries · United Kingdom.
Among the 16 studies in Radiation Injuries with a site in United Kingdom, this one is the only one that started in 2025, is one of 5 with no phase, and was the 15th registered.
328 studies on the registry are indexed under Radiation Injuries; 96 are open to participants now.
Browse Radiation Injuries studies →3 of the 16 studies in Radiation Injuries with a site in United Kingdom are open now. Recruiting first, the newest first:
UMC Utrecht · Sites in United Kingdom, United States, Australia and 6 more countries
Ages 18+
Manchester University NHS Foundation Trust · Sites in United Kingdom
Ages 2–32
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 76 Radiation Injuries studies recruiting now, 52 (68%) set no upper age limit and 14 (18%) stop at 75 or younger; 8 take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 72 across 216 interventional studies indexed under Radiation Injuries.
Median enrollment 84 across the 9 interventional studies, 235 across the 6 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 16 has an industry lead sponsor. The 10 most frequent:
Liverpool Heart and Chest Hospital NHS Foundation Trust is the lead sponsor of 33 studies on the registry; 6 are open to participants now.
Liverpool Heart and Chest Hospital NHS Foundation Trust has 1 study filed under Radiation Injuries — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 16 studies in Radiation Injuries with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Doctors and nurses who perform heart procedures using X-ray guidance are exposed to radiation, which can be harmful over time. This exposure increases the risk of certain health problems, including cancers, eye damage (cataracts), and DNA damage. Although protective lead clothing is used to reduce exposure, it is heavy, uncomfortable, and can cause muscle and joint problems for those who wear it daily.
A new radiation protection device, called RAMPART, may help reduce radiation exposure for heart specialists and their teams. It could also allow them to wear lighter protective gear-or none at all-making their work safer and more comfortable.
This study will compare the radiation levels received by doctors and nurses during heart procedures when using RAMPART versus standard protection. By doing so, we hope to find out if this new device can better protect medical teams from radiation, improving both their safety and well-being.
Recent decades have seen major increases in x-ray guided procedures in interventional cardiology, radiology and vascular surgery. Exposure to ionising radiation is known to be an inherent risk and remains a serious and unresolved threat to the health of operators and their team. It is associated with an increased incidence of brain and blood cancers, cataracts, and recent mechanistic data indicates significantly increased DNA damage in those without leaded leg protection.
Although existing standard radiation protection measures somewhat reduces exposure, all cardiac catheter lab personnel still receive a certain dose of radiation and continue to accumulate lifetime exposure. Furthermore, leaded personal protective equipment is heavy, leads to orthopaedic complications, and detracts from operator comfort.
Novel radiation protection devices such as RAMPART may significantly reduce radiation doses to cardiac catheter lab personnel, and potentially allow the use of lighter lead, or no lead at all. In this study we aim to investigate if use of RAMPART significantly reduces radiation exposure, when compared with standard radiation protection. Standard coronary intervention procedures will be randomised to RAMPART or standard (radiation protection), and operators and Cath lab team doses will be compared.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The use of the RAMPART system to reduce operator radiation exposure
Device: Radiation
Standard radiation protection
The use of RAMPART radiation protection device
Also known as: Use of RAMPART radiation protection device
1st Operator Eye radiation
To assess the effect of using a new medical device (RAMPART) in reducing the amount of radiation the first operator is exposed to (at eye level) when performing coronary angiography or angioplasty. Measurement of radiation in µSv.
Time frame: 1) Periprocedural 2) Cumulative dose - through study completion, an average of 1 year
1st Operator Chest / Groind radiation
To assess if RAMPART significantly reduces the radiation dose to first operators during coronary angiography or angioplasty at chest and groin level. Measurement of radiation in µSv.
Time frame: 1) Periprocedural 2) Cumulative dose - through study completion, an average of 1 year
2nd Operator Radiation - all levels
To assess if RAMPART significantly reduces the radiation dose to second operators during coronary angiography or angioplasty at the level of eye, chest and groin. Measurement of radiation in µSv.
Time frame: 1) Periprocedural 2) Cumulative dose - through study completion, an average of 1 year
'Circulating Nurse' Radiation
To assess if RAMPART significantly reduces radiation dose in a more distant position, consistent with that of a 'circulating nurse'. Measurement of radiation in µSv.
Time frame: 1) Periprocedural 2) Cumulative dose - through study completion, an average of 1 year
Plan to share: Yes — Direct access will be granted to the Sponsor, host institution and the regulatory authorities to permit trial-related monitoring, audits and inspections in line with participant consent. Furthermore, all data will be shared through publication and via online additional data supplements.
Supporting information: Study protocol, Clinical study report
Time frame: End of trial and publication
Access criteria: Published Journal platform Open Source Framework - https://osf.io/
Data sharing details ↗ · osf.io
Started Aug 2025 (actual). Primary completion is estimated for Mar 2026, 6 months after the start.
Of 69 non-industry interventional studies with no phase under Radiation Injuries, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 116. This study's planned 6 months is below that.
Counting every sponsor, half of 72 studies reached it within 43 months; a quarter within 24 and three quarters within 116.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Liverpool Heart and Chest Hospital NHS Foundation Trust